Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors
Mehlika Dilek Altıntop, Belgin Sever, Gülşen Akalın Çiftçi, et al.
European Journal of Medicinal Chemistry (2018) Vol. 155, pp. 905-924
Closed Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Anti-Cancer Activity of Derivatives of 1,3,4-Oxadiazole
Teresa Glomb, Karolina Szymankiewicz, Piotr Świątek
Molecules (2018) Vol. 23, Iss. 12, pp. 3361-3361
Open Access | Times Cited: 149
Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors
Sercan Askin, Hakan Tahtacı, Cüneyt Türkeş, et al.
Bioorganic Chemistry (2021) Vol. 113, pp. 105009-105009
Closed Access | Times Cited: 98
Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK)
Yang Lu, Haiying Sun
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 23, pp. 14382-14403
Closed Access | Times Cited: 76
1,3,4-Oxadiazole-containing hybrids as potential anticancer agents: Recent developments, mechanism of action and structure-activity relationships
Swarnagowri Nayak, Santosh L. Gaonkar, Ebraheem Abdu Musad, et al.
Journal of Saudi Chemical Society (2021) Vol. 25, Iss. 8, pp. 101284-101284
Open Access | Times Cited: 75
Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
Xiaojing Pang, Xiujuan Liu, Yuan Liu, et al.
Molecules (2021) Vol. 26, Iss. 14, pp. 4250-4250
Open Access | Times Cited: 62
The Development of FAK Inhibitors: A Five-Year Update
Andrea Spallarossa, Bruno Tasso, Eleonora Russo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6381-6381
Open Access | Times Cited: 40
2-Aminobenzothiazoles in anticancer drug design and discovery
G. Huang, Tomasz Cierpicki, Jolanta Grembecka
Bioorganic Chemistry (2023) Vol. 135, pp. 106477-106477
Closed Access | Times Cited: 28
A comprehensive review on thiazole based conjugates as anti-cancer agents
Rupali Rana, Nitish Kumar, Harmandeep Kaur Gulati, et al.
Journal of Molecular Structure (2023) Vol. 1292, pp. 136194-136194
Closed Access | Times Cited: 23
Design, synthesis, and anticancer evaluation of novel quinoline derivatives of ursolic acid with hydrazide, oxadiazole, and thiadiazole moieties as potent MEK inhibitors
Xiaoyan Jin, Hao Chen, Dong‐Dong Li, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2019) Vol. 34, Iss. 1, pp. 955-972
Open Access | Times Cited: 62
Antiproliferative activity of thiazole and oxazole derivatives: A systematic review of in vitro and in vivo studies
Nancy Yadira Guerrero Pepinosa, María C. Cardona-Trujillo, Sandra C. Garzón-Castaño, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111495-111495
Open Access | Times Cited: 53
Benzotriazole-oxadiazole hybrid Compounds: Synthesis, anticancer Activity, molecular docking and ADME profiling studies
Arif Mermer, Muhammet Volkan Bülbül, Semiha Mervenur Kalender, et al.
Journal of Molecular Liquids (2022) Vol. 359, pp. 119264-119264
Closed Access | Times Cited: 35
Recent advances in synthetic strategies and SAR of thiazolidin-4-one containing molecules in cancer therapeutics
Archana Sharma, Diksha Sharma, Neha Saini, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 847-889
Open Access | Times Cited: 17
Therapeutic strategies for targeting telomerase in cancer
Xing Chen, Wenjian Tang, Jing Bo Shi, et al.
Medicinal Research Reviews (2019) Vol. 40, Iss. 2, pp. 532-585
Closed Access | Times Cited: 53
Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells
Wen-Yao Zhang, Yangjie Wang, Fan Du, et al.
European Journal of Medicinal Chemistry (2019) Vol. 178, pp. 401-416
Open Access | Times Cited: 50
An extensive research on aldose reductase inhibitory effects of new 4H-1,2,4-triazole derivatives
Belgin Sever, Mehlika Dilek Altıntop, Yeliz Demir, et al.
Journal of Molecular Structure (2020) Vol. 1224, pp. 129446-129446
Closed Access | Times Cited: 49
Thiazole and Related Heterocyclic Systems as Anticancer Agents: A Review on Synthetic Strategies, Mechanisms of Action and SAR Studies
Sahil Sahil, Kamalpreet Kaur, Vikas Jaitak
Current Medicinal Chemistry (2022) Vol. 29, Iss. 29, pp. 4958-5009
Closed Access | Times Cited: 26
In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors
Belgin Sever, Mehlika Dilek Altıntop, Ahmet Özdemır, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 5190-5190
Open Access | Times Cited: 38
Focal adhesion kinase—An emerging viable target in cancer and development of focal adhesion kinase inhibitors
Akshita Chauhan, Tabassum Khan
Chemical Biology & Drug Design (2020) Vol. 97, Iss. 3, pp. 774-794
Closed Access | Times Cited: 38
1,3,4-Oxadiazole N-Mannich Bases: Synthesis, Antimicrobial, and Anti-Proliferative Activities
Lamya H. Al-Wahaibi, Ahmed A. B. Mohamed, Samar S. Tawfik, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2110-2110
Open Access | Times Cited: 31
Novel imidazo[2,1‐b]thiazole‐based anticancer agents as potential focal adhesion kinase inhibitors: Synthesis, in silico and in vitro evaluation
Faika Başoğlu, Nuray Ulusoy‐Güzeldemirci, Gülşen Akalın‐Çiftçi, et al.
Chemical Biology & Drug Design (2021) Vol. 98, Iss. 2, pp. 270-282
Closed Access | Times Cited: 30
Discovery of antiproliferative and anti-FAK inhibitory activity of 1,2,4-triazole derivatives containing acetamido carboxylic acid skeleton
Muhamad Mustafa, Gamal El‐Din A. Abuo‐Rahma, Amer Ali Abd El‐Hafeez, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 40, pp. 127965-127965
Open Access | Times Cited: 27
A Review of the Biological Activities of Heterocyclic Compounds Comprising Oxadiazole Moieties
Ban‐Feng Ruan, Qinglei Guo, Qing‐Shan Li, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 7, pp. 578-599
Closed Access | Times Cited: 19
Development of Novel Focal Adhesion Kinase (FAK) Inhibitors for Targeting Cancer: Structural Insights and Therapeutic Potential
Yingnan Li, Yuming Zhang, Jifa Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116913-116913
Closed Access | Times Cited: 4
Synthesis, anticancer and anti-inflammatory evaluation of novel quinoxaline-1,3,4-oxadiazole derivatives as EGFR and COX-2 inhibitors
Mamdouh F. A. Mohamed, Eman A. Ahmed, Omar Alshazly, et al.
Journal of Molecular Structure (2025), pp. 141651-141651
Closed Access
New 1,3,4-Oxadiazole and 1,2,3-Triazole Derivatives as Anti-Proliferative Agents: Design, Synthesis, Biological Evaluation, in Silico Docking and Dft Studies
S. Kalyani, Sreenivas Gandamalla, Mavurapu Satyanarayana, et al.
(2025)
Closed Access
Page 1 - Next Page

Scroll to top